In April 2016 Manchester eScholar was replaced by the University of Manchester’s
new Research Information Management System, Pure. In the autumn the University’s research
outputs will be available to search and browse via a new Research Portal. Until then
the University’s full publication record can be accessed via a
temporary portal and the old eScholar content is available to search and browse via this archive.
Related resources
Search for item elsewhere
University researcher(s)
Academic department(s)
A randomized phase III trial of afamelanotide (Scenesse®), an agonistic alpha-melanocyte-stimulating hormone (MSH) analogue in the treatment of protoporphyria-induced phototoxicity.
Biolcati G, Deybach J-C, Hanneken S, Wilson P, Wahlin S, Varigos G, Rhodes LE, Aurizi C, Minder C, Coffin B, Neumann N, , De Rooij F, Ross G, Stewart F, Minder E.
In: British Association of Dermatologists Porphyrins & Porphyrias ; 10 Apr 2011-14 Apr 2011; Cardiff, UK. 2011.
Access to files
Full-text and supplementary files are not available from Manchester eScholar. Use our list of Related resources to find this item elsewhere. Alternatively, request a copy from the Library's Document supply service.
Bibliographic metadata
Type of resource:
Content type:
Type of conference contribution:
Conference contribution title:
Publication date:
Conference title:
British Association of Dermatologists Porphyrins & Porphyrias
Conference venue:
Cardiff, UK
Conference start date:
2011-04-10
Conference end date:
2011-04-14
Institutional metadata
University researcher(s):
Academic department(s):
Record metadata
Manchester eScholar ID:
uk-ac-man-scw:121560
Created by:
Rhodes, Lesley
Created:
6th April, 2011, 11:32:40
Last modified:
6th December, 2011, 12:52:34